publication venue for
- Inability of positive phase II clinical trials of investigational treatments to subsequently predict positive phase III clinical trials in glioblastoma.. 20:113-122. 2018
- Immune modulatory nanoparticle therapeutics for intracerebral glioma.. 19:372-382. 2017
- EPID-17. DEMOGRAPHIC AND PRIMARY TUMOR LOCATION PROGNOSTIC FACTORS IN GLIOBLASTOMA SURVIVAL. 18:vi59-vi59. 2016
- Creation of an NCI comparative brain tumor consortium: informing the translation of new knowledge from canine to human brain tumor patients.. 18:1209-1218. 2016
- IMPS-41IMMUNE MODULATORY NANOPARTICLE THERAPEUTICS. 17:v122.1-v122. 2015
- AI-06 * NON-CANONICAL NF-kB SIGNALING DRIVES THE AGGRESSIVE INVASIVENESS OF GLIOBLASTOMA. 16:v2-v2. 2014
- ZIP4 is a novel molecular marker for glioma.. 15:1008-1016. 2013
- DEMOGRAPHIC AND PRIMARY TUMOR LOCATION PROGNOSTIC FACTORS IN GLIOBLASTOMA SURVIVAL 2016